InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-82.1%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Mertens Steve, Chief Technology Officer. Insider active across 1 company, notably NEUROONE MEDICAL TECHNOLOGIES Corp. Cumulatively, 34 reports have been recorded. History available since 3 February 2022. The latest transaction was filed on 31 March 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Declarations34 total
906 shares@ US$0.7771.8% of flowCommon StockSEC:0001772652-26-000005:0
906 shares@ US$0.8886Common StockSEC:0001772652-25-000006:0
906 shares@ US$0.6781.5% of flowCommon StockSEC:0001540354-25-000007:0
906 shares@ US$0.85022.1% of flowCommon StockSEC:0001772652-25-000003:0
7,376 shares@ US$1.1624.6% of flowCommon StockSEC:0001772652-25-000002:0
252 shares@ US$1.150.8% of flowCommon StockSEC:0001772652-25-000001:0
1,158 shares@ US$0.8262.8% of flowCommon StockSEC:0001213900-25-000720:0
252 shares@ US$0.62310.4% of flowCommon StockSEC:0001772652-24-000013:0
252 shares@ US$0.970.7% of flowCommon StockSEC:0001772652-24-000012:0
1,158 shares@ US$0.993.1% of flowCommon StockSEC:0001772652-24-000011:0
252 shares@ US$0.79640.5% of flowCommon StockSEC:0001772652-24-000010:0
252 shares@ US$0.750.5% of flowCommon StockSEC:0001772652-24-000009:0
1,158 shares@ US$0.802.6% of flowCommon StockSEC:0001772652-24-000008:0
252 shares@ US$0.92990.7% of flowCommon StockSEC:0001772652-24-000007:0
252 shares@ US$1.130.8% of flowCommon StockSEC:0001772652-24-000006:0
7,250 shares@ US$1.1523.5% of flowCommon StockSEC:0001772652-24-000005:0
252 shares@ US$1.200.8% of flowCommon StockSEC:0001772652-24-000004:0
252 shares@ US$1.210.8% of flowCommon StockSEC:0001772652-24-000003:0
101,743 shares0Common StockSEC:0001772652-24-000002:0
252 shares@ US$1.250.9% of flowCommon StockSEC:0001772652-24-000001:0
252 shares@ US$1.581.1% of flowCommon StockSEC:0001213900-24-000532:0
252 shares@ US$1.451.0% of flowCommon StockSEC:0001772652-23-000013:0
252 shares@ US$1.611.2% of flowCommon StockSEC:0001772652-23-000011:0
252 shares@ US$0.900.6% of flowCommon StockSEC:0001772652-23-000010:0
252 shares@ US$0.89040.6% of flowCommon StockSEC:0001772652-23-000009:0
25 of 34 declarations
About Mertens Steve
Steve Mertens is the Chief Technology Officer of NeuroOne Medical Technologies Corp. He is responsible for leading technology initiatives and innovation within the company. With expertise in medical product development, he contributes to enhancing the technological solutions offered by the company.
